The table below shows ATOSSA THERAPEUTICS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$29.76M
-$21.03M
-$20.94M
-$20.76M
-$16.47M
-$11.57M
Capital expenditure
$23.00K
$19.00K
$14.00K
$27.00K
$9.00K
$9.00K
Investing cash flow
-$23.00K
-$19.00K
-$14.00K
-$4.73M
-$9.00K
-$9.00K
Dividends paid
-
-
-
-
ATOS operating cash flow (10-K history)
ATOSSA THERAPEUTICS, INC. reported operating cash flow of -$29.76M for fiscal year 2025. That is down 41.5% from -$21.03M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.37M (FY 2016) to -$29.76M. Figures come from the company's audited annual reports as filed with the SEC.